FDA-cleared profile

Critical Care Suite with Endotracheal Tube Positing AI algorithm

GE Medical Systems, LLC · X-ray/Radiography · FDA-cleared (510(k))

Authorized purpose: Analyzes frontal chest X-rays to detect and localize an endotracheal tube, tube tip, and carina and calculate their vertical distance for radiologist review.

Clinical role
Produces an on-screen image overlay localizing the endotracheal tube, tube tip, and carina and calculating the tip-to-carina vertical distance, also transmitted to the radiologist for review; it does not replace qualified professional review of the X-ray.
Images and patients
X-ray/Radiography · Chest/Lung; endotracheal tube, tube tip, and carina
Key limitation
Keep in mind: Not a substitute for full evaluation, sole diagnosis, or X-ray review; distance is measured in the detector imaging plane and does not account for geometric magnification, SID, patient size, or patient or tube rotation.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: Analyzes frontal chest X-rays to detect and localize an endotracheal tube, tube tip, and carina and calculate their vertical distance for radiologist review.
  • Which images or clinical context are in scope?Modality: X-ray/Radiography Anatomy or clinical context: Chest/Lung; endotracheal tube, tube tip, and carina Input: Frontal chest X-rays from a digital X-ray system for adult-size patients.
  • Who uses it?Intended users: Licensed qualified healthcare professionals trained to place or assess endotracheal tubes and radiologists.
  • What does the software produce?Output: On-screen overlay identifying and localizing the tube, tube tip, and carina, with calculated tip-to-carina distance transmitted to the radiologist.
  • What is its most important limitation?Key limitation: Not a substitute for full evaluation, sole diagnosis, or X-ray review; distance is measured in the detector imaging plane and does not account for geometric magnification, SID, patient size, or patient or tube rotation.

Clinical takeaway. Clinical role: Analyzes frontal chest X-rays to detect and localize an endotracheal tube, tube tip, and carina and calculate their vertical distance for radiologist review.

Evidence takeaway. Evidence from the reviewed source record: FDA-reported nonclinical verification, regression and integration testing, simulated testing, and ground-truth clinical testing; packet metrics remain submission-reported evidence only.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
Analyzes frontal chest X-rays to detect and localize an endotracheal tube, tube tip, and carina and calculate their vertical distance for radiologist review.
  • Exact FDA submission
  • Checked 2026-09-19

Clinical-use display mirrors the exact FDA-supported purpose reconciled in this remediation finding.

Workflow role
Produces an on-screen image overlay localizing the endotracheal tube, tube tip, and carina and calculating the tip-to-carina vertical distance, also transmitted to the radiologist for review; it does not replace qualified professional review of the X-ray.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "produces an on-screen image overlay that detects and localizes an endotracheal tube, locates the endotracheal tube tip, locates the carina, and automatically calculates the vertical distance between the endotracheal tube tip and carina." … "This information is also transmitted to the radiologist for review.". Read from the exact FDA decision document on 2026-11-14.

Required input
Frontal chest X-rays from a digital X-ray system for adult-size patients.
  • Exact FDA submission
  • Checked 2026-09-19

FDA packet input and population scope.

Output and clinician action
On-screen overlay identifying and localizing the tube, tube tip, and carina, with calculated tip-to-carina distance transmitted to the radiologist.
  • Exact FDA submission
  • Checked 2026-09-19

FDA packet output scope.

Care setting
Adult
  • Exact FDA submission
  • Checked 2026-09-01

Patient-population text reported in the exact-submission ACR model card; institutional setting may still require vendor confirmation.

Intended users
Licensed qualified healthcare professionals trained to place or assess endotracheal tubes and radiologists.
  • Exact FDA submission
  • Checked 2026-09-19

FDA packet intended-user statement.

Limitations
Not a substitute for full evaluation, sole diagnosis, or X-ray review; distance is measured in the detector imaging plane and does not account for geometric magnification, SID, patient size, or patient or tube rotation.
  • Exact FDA submission
  • Checked 2026-09-19

Exact FDA limitation boundary.

Evidence summary
FDA-reported nonclinical verification, regression and integration testing, simulated testing, and ground-truth clinical testing; packet metrics remain submission-reported evidence only.
  • Exact FDA submission
  • Checked 2026-09-19

Do not generalize the submission testing as a clinical-performance claim.

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
FDA-reported nonclinical verification, regression and integration testing, simulated testing, and ground-truth clinical testing; packet metrics remain submission-reported evidence only.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-19

Do not generalize the submission testing as a clinical-performance claim.

Reported sensitivity
99.40%
  • Public source
  • Exact FDA submission
  • Checked 2026-09-01

Model sensitivity reported by ACR AI Central. Review endpoint, threshold, study population, and tested version before comparison.

Reported specificity
100%
  • Public source
  • Exact FDA submission
  • Checked 2026-09-01

Model specificity reported by ACR AI Central. Review endpoint, threshold, study population, and tested version before comparison.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

Critical Care Suite with Endotracheal Tube Positioning AI Algorithm regulatory performance study summary

  • DesignStand-Alone Performance
  • PopulationAdult
  • Scopeexact submission
  • Tested version2
  • IndependenceIndependence not established

K211161

ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K211161. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-09
Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not verified: Pricing information is recorded but not verified against a resolving source.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Frontal chest X-rays from a digital X-ray system for adult-size patients.

    Scope: Exact FDA submission. FDA packet input and population scope.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-19 · FDA K211161: Critical Care Suite with Endotracheal Tube Positing AI algorithm

  2. Routing

    Source context, not route validation: The exact FDA package describes results reaching the radiologist immediately after images are sent to PACS via a secondary capture image and DICOM tag. Interface versions and local compatibility require confirmation.

    Scope: Exact FDA submission. Packet wording: "Radiologist – immediately after images are sent to PACS via secondary capture image and DICOM tag". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-11-14 · FDA K211161: Critical Care Suite with Endotracheal Tube Positing AI algorithm

  3. AI processing

    Source context, not route validation: The exact FDA package describes the algorithm as deployable on computing platforms such as PACS, on premise, on cloud or imaging systems, with the Optima XR240amx chosen as the initial deployment platform and validated with the algorithm integrated. Current hosting, data flow, and commercial configuration require vendor confirmation.

    Scope: Exact FDA submission. Packet wording: "It is a deep learning locked AI algorithm that can be deployed on several computing platforms such as PACS, On Premise, On Cloud or Imaging Systems." … "The Optima XR240amx was chosen as the initial platform for deployment because endotracheal tube placement images are almost exclusively acquired on mobile X-ray systems". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-11-14 · FDA K211161: Critical Care Suite with Endotracheal Tube Positing AI algorithm

  4. Returned objects

    Source context, not route validation: On-screen overlay identifying and localizing the tube, tube tip, and carina, with calculated tip-to-carina distance transmitted to the radiologist.

    Scope: Exact FDA submission. FDA packet output scope.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-19 · FDA K211161: Critical Care Suite with Endotracheal Tube Positing AI algorithm

  5. Viewer/worklist/report

    Unresolved route: On-screen overlay identifying and localizing the tube, tube tip, and carina, with calculated tip-to-carina distance transmitted to the radiologist.

    Scope: Exact FDA submission. FDA packet output scope.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-19 · FDA K211161: Critical Care Suite with Endotracheal Tube Positing AI algorithm

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
The exact FDA package describes the algorithm as deployable on computing platforms such as PACS, on premise, on cloud or imaging systems, with the Optima XR240amx chosen as the initial deployment platform and validated with the algorithm integrated. Current hosting, data flow, and commercial configuration require vendor confirmation.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "It is a deep learning locked AI algorithm that can be deployed on several computing platforms such as PACS, On Premise, On Cloud or Imaging Systems." … "The Optima XR240amx was chosen as the initial platform for deployment because endotracheal tube placement images are almost exclusively acquired on mobile X-ray systems". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

Integration
The exact FDA package describes results reaching the radiologist immediately after images are sent to PACS via a secondary capture image and DICOM tag. Interface versions and local compatibility require confirmation.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "Radiologist – immediately after images are sent to PACS via secondary capture image and DICOM tag". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

Security
GE HealthCare's Product Security Portal is described as a credentialed global portal giving customers security updates, vulnerability status and required actions for GE HealthCare products potentially impacted by critical vulnerabilities, plus historical patch views; GE HealthCare references its Cybersecurity Risk Management System and publishes a Coordinated Vulnerability Disclosure Statement for reporting vulnerabilities in GE HealthCare products.
  • Vendor-wide
  • Checked 2026-10-26

Vendor statement, not an attestation. Identity bridge: GE HealthCare's own Privacy Shield page on gehealthcare.com names GE Medical Systems LLC as a US entity of the GEHC group. Corporate program statement; portal content is credentialed; exact-release scope is not established.

Monitoring
GE HealthCare's product security page states that it provides a credentialed Product Security Portal offering security updates, vulnerability status and actions, and patch views for GE HealthCare products under its Cybersecurity Risk Management System, and links its Coordinated Vulnerability Disclosure Statement.
  • Vendor-wide
  • Checked 2026-10-27

Vendor statement, not an attestation. The page names GE HealthCare generally and does not scope these commitments to any specific product release; exact-release scope is not established. Portal access is credentialed; contents were not read.

ACR exact-submission catalog context

ACR AI Central provides an exact-submission model card for Critical Care Suite with Endotracheal Tube Positing AI algorithm; FDA labeling remains controlling for clinical use, limitations, and performance.

exact submission · checked 2026-09-09
Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K211161
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
X-ray/Radiography
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-19

FDA packet frontal chest radiography scope.

Anatomy
Chest/Lung; endotracheal tube, tube tip, and carina
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-19

Exact FDA anatomy and device-positioning scope.

Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2021-10-29
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Exact FDA record reviewedStatus
2026-09-20Last searched
26Fields reviewed
10Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads

The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, acr ai central product, fda device recall, literature index, trial registry, fda decision summary packet, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not verified - checked 2026-09-09 - Exact FDA submission

    No public price or quote for the exact K211161 configuration was established in this review.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-09-09 - Exact FDA submission

    No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Installation timeline: Not yet reviewed
  • Training: Not verified - checked 2026-09-09 - Exact FDA submission

    Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.

8 sources - 3 history items

Source ledger

  1. FDA K211161: Critical Care Suite with Endotracheal Tube Positing AI algorithm

    U.S. Food and Drug Administration - Published 2021-10-29 - Accessed 2026-09-09

    Scope: identity, clinicalUse, modality, anatomy, workflow, evidence, implementation, purpose, intendedUsers, input, output, limitations, evidenceSummary, deployment, integration

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. Critical Care Suite with Endotracheal Tube Positioning AI Algorithm model card (K211161)

    American College of Radiology - Published 2026-08-17 - Accessed 2026-09-01

    Scope: intendedUsers, careSetting, output, limitations, reportedSensitivity, reportedSpecificity, evidenceSummary, anatomy, evidenceStudies

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. openFDA exact recall query for K211161

    U.S. Food and Drug Administration - Accessed 2026-09-09

    Scope: postmarketSafety

  8. GE HealthCare: Product Security (portal and Cybersecurity Risk Management System)

    GE HealthCare - Accessed 2026-10-26

    Scope: security

Research history

  1. K211161 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    fda record reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K252953

Velmeni for Dentists (V4D) Endo-Perio

Velmeni, Inc.

Authorized purpose: Concurrent-read CADe to assist dentists in detecting specified tooth and jaw anatomy, bone-level landmarks, and root-canal-treated teeth in digital radiographs of permanent teeth in patients 15 years or older.

Modality
X-ray/Radiography
Anatomy
Permanent teeth and jaw/maxillofacial anatomy, including enamel, dentine, pulp, root, mental foramen, inferior alveolar canal, maxillary sinus, cementoenamel junction, crestal bone, and root-canal-treated teeth
Decision
2026-05-11
FDA-cleared K253502

Critical Care Suite with Enteric Tube Positioning AI Algorithm

Ge Medical Systems, LLC

Authorized purpose: Analyze frontal chest and abdominal X-ray images to detect and localize a nasally or orally inserted enteric tube, its tip and side port if present, and the diaphragm and airways for radiologist review.

Modality
X-ray/Radiography
Anatomy
Chest/lung and abdomen/stomach; enteric tube, tube tip and side port, diaphragm, and airways including carina and left/right bronchi
Decision
2026-04-14
FDA-cleared K251934

qXR-Detect

Qure.Ai Technologies

Authorized purpose: qXR-Detect is an adult chest-radiograph concurrent reading aid that identifies, highlights and categorizes suspicious regions of interest across lung, pleura, mediastinum/hila/heart, bone, hardware and other categories; trained clinicians remain responsible for primary interpretation.

Modality
X-ray/Radiography
Anatomy
Chest/Lung; pleura, mediastinum/hila/heart, bone, hardware and other chest-radiograph regions
Decision
2026-01-16
FDA-cleared K250264

SugarBug (1.x)

Bench7, Inc.

Authorized purpose: Provides automated concurrent-read detection and segmentation of caries on bitewing radiographs in patients 18 and older, adding information for the dentist while requiring complete dentist review and judgment.

Modality
X-ray/Radiography
Anatomy
Dental/Maxillofacial
Decision
2025-11-07

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history